Mannatech (MTEX) Competitors $11.30 +0.80 (+7.62%) (As of 12/5/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends MTEX vs. BYSI, XFOR, IMRX, PASG, ALVR, CLRB, ALRN, CRVO, ITRM, and SPROShould you be buying Mannatech stock or one of its competitors? The main competitors of Mannatech include BeyondSpring (BYSI), X4 Pharmaceuticals (XFOR), Immuneering (IMRX), Passage Bio (PASG), AlloVir (ALVR), Cellectar Biosciences (CLRB), Aileron Therapeutics (ALRN), CervoMed (CRVO), Iterum Therapeutics (ITRM), and Spero Therapeutics (SPRO). These companies are all part of the "pharmaceutical products" industry. Mannatech vs. BeyondSpring X4 Pharmaceuticals Immuneering Passage Bio AlloVir Cellectar Biosciences Aileron Therapeutics CervoMed Iterum Therapeutics Spero Therapeutics BeyondSpring (NASDAQ:BYSI) and Mannatech (NASDAQ:MTEX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability, community ranking and analyst recommendations. Which has more risk & volatility, BYSI or MTEX? BeyondSpring has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500. Comparatively, Mannatech has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Does the MarketBeat Community prefer BYSI or MTEX? Mannatech received 123 more outperform votes than BeyondSpring when rated by MarketBeat users. Likewise, 76.43% of users gave Mannatech an outperform vote while only 66.79% of users gave BeyondSpring an outperform vote. CompanyUnderperformOutperformBeyondSpringOutperform Votes18566.79% Underperform Votes9233.21% MannatechOutperform Votes30876.43% Underperform Votes9523.57% Is BYSI or MTEX more profitable? BeyondSpring has a net margin of 0.00% compared to Mannatech's net margin of -1.26%. BeyondSpring's return on equity of 0.00% beat Mannatech's return on equity.Company Net Margins Return on Equity Return on Assets BeyondSpringN/A N/A N/A Mannatech -1.26%-15.62%-3.76% Which has higher earnings & valuation, BYSI or MTEX? Mannatech has higher revenue and earnings than BeyondSpring. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeyondSpring$1.75M38.53-$21.03MN/AN/AMannatech$131.96M0.14-$2.24M-$0.81-12.36 Does the media prefer BYSI or MTEX? In the previous week, Mannatech had 1 more articles in the media than BeyondSpring. MarketBeat recorded 1 mentions for Mannatech and 0 mentions for BeyondSpring. Mannatech's average media sentiment score of 0.93 beat BeyondSpring's score of 0.00 indicating that Mannatech is being referred to more favorably in the news media. Company Overall Sentiment BeyondSpring Neutral Mannatech Positive Do insiders and institutionals have more ownership in BYSI or MTEX? 40.3% of BeyondSpring shares are owned by institutional investors. Comparatively, 13.0% of Mannatech shares are owned by institutional investors. 29.3% of BeyondSpring shares are owned by insiders. Comparatively, 41.5% of Mannatech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryMannatech beats BeyondSpring on 8 of the 13 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Mannatech News Delivered to You Automatically Sign up to receive the latest news and ratings for MTEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MTEX vs. The Competition Export to ExcelMetricMannatechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.82M$1.21B$5.22B$9.16BDividend YieldN/AN/A5.72%4.01%P/E Ratio-12.3627.40101.6214.88Price / Sales0.147.291,262.2588.47Price / CashN/A11.2241.5038.06Price / Book1.772.114.754.94Net Income-$2.24M-$51.46M$119.18M$224.89M7 Day Performance27.35%-4.08%2.46%1.84%1 Month Performance17.76%-10.57%1.97%9.06%1 Year Performance13.62%1.78%32.04%28.59% Mannatech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MTEXMannatech1.0981 of 5 stars$11.30+7.6%N/A+19.0%$21.24M$131.96M-13.95250Analyst ForecastNews CoverageGap UpHigh Trading VolumeBYSIBeyondSpringN/A$1.72-10.9%N/A+89.4%$67.13M$1.75M0.0080Gap DownXFORX4 Pharmaceuticals4.1121 of 5 stars$0.39-0.8%$2.88+637.2%-53.5%$66.51MN/A-4.3780IMRXImmuneering2.7748 of 5 stars$2.10+0.5%$12.80+509.5%-72.3%$65.21M$320,000.00-1.0660PASGPassage Bio3.4652 of 5 stars$1.04-8.4%$7.75+648.8%+17.9%$63.93MN/A-0.91130High Trading VolumeALVRAlloVir2.6073 of 5 stars$0.55+0.1%N/A-74.8%$63.41MN/A-0.61110Positive NewsGap UpCLRBCellectar Biosciences2.3557 of 5 stars$1.54-0.3%$20.00+1,202.9%-41.2%$63.35MN/A-0.9010Analyst ForecastALRNAileron Therapeutics3.6155 of 5 stars$2.92+2.1%$19.00+550.7%-2.9%$63.28MN/A-0.929Positive NewsGap DownCRVOCervoMed1.7095 of 5 stars$10.20-5.6%$50.33+393.5%+5.3%$62.93M$7.14M0.004Analyst ForecastGap UpHigh Trading VolumeITRMIterum Therapeutics1.7176 of 5 stars$2.26+11.9%$5.00+121.2%+13.3%$62.19MN/A-1.1010Short Interest ↑SPROSpero Therapeutics4.7705 of 5 stars$1.13-0.9%$5.00+342.5%-4.1%$61.61M$103.78M16.2946Analyst ForecastAnalyst RevisionNews CoveragePositive News Related Companies and Tools Related Companies BYSI Alternatives XFOR Alternatives IMRX Alternatives PASG Alternatives ALVR Alternatives CLRB Alternatives ALRN Alternatives CRVO Alternatives ITRM Alternatives SPRO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MTEX) was last updated on 12/5/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTrump’s Bold Move Could Change the Market ForeverAmerica’s Return to Gold? New economic vision could reshape your entire retirement strategy… Gold Safe Exchange | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mannatech, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Mannatech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.